Diets · Metabolic & Cardiometabolic
dietary linoleic acid / seed oils causes insulin resistance and metabolic dysfunction
In plain terms: Do seed oils high in omega-6 cause insulin resistance and metabolic problems?
Part of: 🔍 seed oils
Controlled human trials and pooled biomarker data show linoleic acid is neutral-to-beneficial for insulin sensitivity and lowers diabetes risk, so the insulin-resistance claim leans strongly against the evidence in humans.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Controlled trials point the opposite way: pooled feeding trials show plant polyunsaturated fat, mostly linoleic acid, replacing saturated fat or carbohydrate lowers fasting insulin and HOMA-IR, high-linoleic safflower oil improved glycaemic control in a randomised trial, and across 30 cohorts higher linoleic-acid biomarkers track lower cardiometabolic mortality.
The evidence (13)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Norris LE, Collene AL, Asp ML, Hsu JC, Liu LF, Richardson JR, Li D, Bell D, Osei K, Jackson RD, Belury MA 2009 · Am J Clin Nutr | RCT | contradicts | moderate | High-linoleic safflower oil improved glycemic control (lower HbA1c, fasting glucose) in obese postmenopausal women with type 2 diabetes. |
| Almolafikh ST, Subash-Babu P, Barhoumi T, Alshatwi AA 2026 · Metabolites | in-vitro | tested-null | low | In human mesenchymal stem cell-derived adipocytes, a 1:3 omega-3:omega-6 ratio (i.e., omega-6 dominant, 20:60 uM) produced the most favorable (lean) adipocyte phenotype versus more omega-6-skewed or neutral ratios, while unhealthy AT expansion was linked to 'e |
| Al Sinani M, Johnson M, Crawford M, Al Maqbali M 2026 · BMC Pregnancy Childbirth | observational | contradicts | low | In pregnant Omani women, gestational diabetes (GDM, associated with insulin resistance) was linked to LOWER omega-3 and lower arachidonic acid/DHA levels; cord erythrocytes of GDM women also showed significantly lower LA, arachidonic acid, DHA, and total n-6 F |
| Marklund M, Wu JHY, Imamura F, Del Gobbo LC, Fretts A, de Goede J, Shi P, Tintle N, Wennberg M, Aslibekyan S, Chen TA, de Oliveira Otto MC, Hirakawa Y, Eriksen HH, Kröger J, Laguzzi F, Lankinen M, Murphy RA, Prem K, Samieri C, Virtanen J, Wood AC, Wong K, Yang WS, Zhou X, Baylin A, Boer JMA, Brouwer IA, Campos H, Chaves PHM, Chien KL, de Faire U, Djoussé L, Eiriksdottir G, El-Abbadi N, Forouhi NG, Michael Gaziano J, Geleijnse JM, Gigante B, Giles G, Guallar E, Gudnason V, Harris T, Harris WS, Helmer C, Hellenius ML, Hodge A, Hu FB, Jacques PF, Jansson JH, Kalsbeek A, Khaw KT, Koh WP, Laakso M, Leander K, Lin HJ, Lind L, Luben R, Luo J, McKnight B, Mursu J, Ninomiya T, Overvad K, Psaty BM, Rimm E, Schulze MB, Siscovick D, Skjelbo Nielsen M, Smith AV, Steffen BT, Steffen L, Sun Q, Sundström J, Tsai MY, Tunstall-Pedoe H, Uusitupa MIJ, van Dam RM, Veenstra J, Monique Verschuren WM, Wareham N, Willett W, Woodward M, Yuan JM, Micha R, Lemaitre RN, Mozaffarian D, Risérus U, Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCE) 2019 · Circulation | observational | contradicts | high | Higher linoleic-acid biomarkers tied to lower cardiometabolic mortality across 30 cohorts, inconsistent with an insulin-resistance harm pathway. |
| Suchner U 2026 · Nutrients | observational | supports | low | Narrative review argues excess dietary n-6 PUFA (linoleic acid), highly prevalent in the Western diet, drives PUFA-eicosanoid imbalance, impaired adipose tissue expandability, functional lipodystrophy, and insulin resistance via lipotoxicity; proposes reducing |
| Wanders AJ, Blom WAM, Zock PL, Geleijnse JM, Brouwer IA, Alssema M 2019 · BMJ Open Diabetes Res Care | meta-analysis | contradicts | high | Meta-analysis of RCT feeding trials: plant PUFA (mainly LA) replacing SFA/carbs lowered fasting insulin and HOMA-IR; no glucose worsening. |
| Imamura F, Sharp SJ, Koulman A, Schulze MB, Kröger J, Griffin JL, Huerta JM, Guevara M, Sluijs I, Agudo A, Ardanaz E, Balkau B, Boeing H, Chajes V, Dahm CC, Dow C, Fagherazzi G, Feskens EJM, Franks PW, Gavrila D, Gunter M, Kaaks R, Key TJ, Khaw KT, Kühn T, Melander O, Molina-Portillo E, Nilsson PM, Olsen A, Overvad K, Palli D, Panico S, Rolandsson O, Sieri S, Sacerdote C, Slimani N, Spijkerman AMW, Tjønneland A, Tumino R, van der Schouw YT, Langenberg C, Riboli E, Forouhi NG, Wareham NJ 2017 · PLoS Med | observational | contradicts | high | EPIC-InterAct case-cohort found plasma linoleic acid inversely associated with incident type 2 diabetes. |
| Wu 2017 · Lancet Diabetes Endocrinol | observational | contradicts | high | Pooled 20-cohort biomarker analysis (39,740 adults): higher linoleic acid associated with significantly lower incident type 2 diabetes. |
| Schwab U, Lauritzen L, Tholstrup T, Haldorssoni T, Riserus U, Uusitupa M, Becker W 2014 · Food Nutr Res | meta-analysis | contradicts | moderate | Nordic systematic review found biomarker linoleic acid inversely (suggestively) related to type 2 diabetes risk and PUFA-for-SFA replacement lowers LDL. |
| Mousavi SM, Jalilpiran Y, Karimi E, Aune D, Larijani B, Mozaffarian D, Willett WC, Esmaillzadeh A 2021 · Diabetes Care | meta-analysis | contradicts | high | Dose-response meta-analysis of prospective cohorts found higher linoleic acid intake and biomarker levels associated with LOWER, not higher, type 2 diabetes risk. |
| Chiva-Blanch G, Giró O, Cofán M, Calle-Pascual AL, Delgado E, Gomis R, Jiménez A, Franch-Nadal J, Rojo Martínez G, Ortega E 2022 · Nutrients | observational | contradicts | moderate | In the Di@bet.es cohort linoleic acid showed no significant association with incident diabetes (neither harmful nor protective). |
| Alvheim AR, Malde MK, Osei-Hyiaman D, Lin YH, Pawlosky RJ, Madsen L, Kristiansen K, Frøyland L, Hibbeln JR 2012 · Obesity (Silver Spring) | animal | mixed | moderate | High-LA mouse diet induced obesity/metabolic change via endocannabinoids; mechanism exists in rodents but does not reproduce in human trials. |
| Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, Rudling M, Arner P, Cederholm T, Ahlström H, Risérus U 2012 · Am J Clin Nutr | RCT | contradicts | high | Replacing SFA with n-6 PUFA reduced liver fat (a driver of insulin resistance) without raising inflammation in abdominal obesity. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.